Member Info for ForFXSake

Shame the video chose to talk about NXP002. Didn't seem to register that there is a link between AB and AZN nor that the discussion boards are rife about NXP004 and Lynparza.

Lack of research?

AZN looks a bit too risky for my portfolio, I'm afraid. My gut tells me that big pharma looks like it might too much of gravy train with a high turnover of execs who flee at the first sign of a challenge.

I'll stick to the tried and tested NFX.

LOL!

So we hit 15p in mid 2019 then sank back to about 6p before the Times leak pushed us back up to 14p at the end of the year.

If what you say is right then the Chinese default left us unable to further our plans for NXP002, which may have delayed or possibly killed any deal mentioned by the Times leak.

However, earlier this year we saw a placing which did raise the money that would have been reimbursed for NXP001 and we are now beyond the development point we were at with NXP002 back then. The deal may no longer stand so that should have placed us back to around 6p value?

I know we supposedly had the NSB & Ebers deal back then but we now have Oxilio along with whatever upfront payment that generated. We also have what looks to be positive data for NXP004, a billion+ revenue generator for big pharma which could worth multiples of what Ebers was valued at.

In the face of that, 1.6p seems like a ridiculous and deliberate undervaluation, would you not agree?

I would love to know what criteria was used to arrive at the RTO valuation of 4p per share and compare it to that used for the current valuation of 1.6p per share.

They must be very different.

Unfortunately that is where we seem to fall down Chab.

We've had a succession of execs who have fled the company over the past 2 years without delivering anything and mostly without explanation.

Our current CEO, while appearing to deliver the data packages she promised, is not going to be around to do anything with them.

I think this is why no large investors want to touch this at the moment. This is why it is now so important for Riddell to find a successor who we can rely to deliver and stay committed.

That is reassuring to know OBW.

If they have said that they can approach the originator immediately after filing then they must be confident that it can go through unhindered.

There might be further news to come on it before the year is out then

Not convinced we're in the clear yet by the market and BoD reaction so far.

NXP004 results release in Q4 was bigged up for the placing. We all expected fireworks. Now it looks like they want it hushed while the patent is processed. If that's the case then it might be too risky to approach the originator before approval (which could be 12 months or more away). Who is to say that the originator might not try to use legal/financial muscle to derail the patent to acquire the IP on the cheap.

If that is the case and NXP002 doesn't deliver then we could have a long wait which might require a further placing in between.

Is that why no one held their placing shares and is that why no big takers are interested right now?

If today's news is not substantial Chab, then I'm not sure what is.

You might have to read between the lines but the submission of the patent is evidence that the results are good.

It may be worth nothing until the patent is approved. That could be the reason why it remains stagnant but I think the jitters that AB caused when she resigned will remain until a suitable alternative is found or it transpires that we won't need one because of a buyout.

There are no decent buys Soup.

Something else is holding this back. There is no other reason that I can think of why bigger investors are not piling in here other than that they still see huge uncertainty. I would never have expected this share to close below 4p on good NXP004 news, let alone 2p

I don't think it's going to change until we either get a new CEO or a buyout is announced.

"Clearing sellers first"

Haven't we been doing that for past 2 years? :0)

Let's hope they announce something about a replacement CEO soon.

I can't think of anything else that could be keeping the price so suppressed.

I find it incredible that on the morning that this news is released, after so much anticipation, that the biggest trade yet is still less than 10k!

This must be the best kept secret on the stock market.

1.7p to 3.4p before any news or deals.

We should get an Allenby update at some point regarding NXP004 as they covered this before.

They might be able to give some indication at least of how this affects the market cap

Yes, I get that Soup.

Over caution might look suspiciously like downplaying for other reasons though.

Dunno Filter.

There could be a valid reason, such as protecting the patent but it would hurt to explain that further details will be released once the patent is secure.

It looks like a win, it would be nice to some excitement from the board though. Let's see if an interview comes out.

I wonder if this might trigger the search for a new CEO?

They said new patents would be submitted if results were good so I assume that is what this means.

It seems a bit muted. I would hope have hoped for a little more excitement from the company. Surely they can do some bragging without giving anything sensitive away.

Let's see if we get an interview.

Does anyone know what Oxilio's OXL002 is based on yet? Is it a different application of NXP001 (compared to OXL001) or is it based on something else?

If NXP001 based, will this trigger further milestones in addition to OXL001? I'm assuming that the 2m per annum cap would cover all indications that they might create based on NXP001?

"I would be amazed if Anne (being the professional she is) didn't tell the board before the RNS."

Perhaps you are right Soup, I was amazed that her decision to leave was described as "out of the blue". I also find it hard to believe that AB was unaware that she would be approached for the job until she got the actual call.

I see. Thanks

I thought Riddell said it was as much a surprise to the board as it was to us. Where did you hear that he'd known for a week?

If she wanted to leave with immediate effect then that would suggest she was running away from it. She'd have to be pretty naive to think that she'd be allowed to simply leave the company in the lurch without doing even more damage.

Let's just hope she can deliver on what she promised and the data driven approach doesn't end up being a complete waste of time and money.